Back to search

Article

Neutrophils cause critical illness in COVID-19 and reveal CDK6 inhibitors as potential treatment

2021-05-20

Abstract excerpt

<h4>Background</h4> Despite recent development of vaccines and monoclonal antibodies to prevent SARS-CoV-2 infection, treatment of critically ill COVID-19 patients remains an important goal. In principle, genome-wide association studies (GWAS) could shortcut the clinical evidence needed to repurpose drugs - the use of an existing drug for a new indication. However, it has been shown that the genes found in GWA stu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b92d0a83-7e44-5049-84de-0049e10394da
DOI
10.1101/2021.05.18.21256584
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Neutrophils cause critical illness in COVID-19 and reveal CDK6 inhibitors as potential treatmentDOI 10.1101/2021.05.18.21256584
Select a neighboring publication to make it the new centre.